** Shares of Sichuan Kelun-Biotech Biopharmaceutical 6990.HK fall 6.4% to HK$336, on course for the biggest one-day drop since May 7
** Stock on track to snap two straight sessions of gains
** The oncology-focused drug developer plans sale of 5.92 mln new shares, or 2.5% of the enlarged share capital, in share placement raising HK$1.96 bln ($249.8 mln) for R&D, products commercialization and expanding product pipeline portfolio
** The new shares will be issued at HK$331.8 apiece, or 7.6% discount to Wednesday's close of HK$359 each
** Hang Seng Biotech Index .HSHKBIO slips 0.7%, while Hang Seng Index .HSI climbs 0.7%
** YTD, stock up 107.6%
($1 = 7.8452 Hong Kong dollars)
(Reporting by Donny Kwok)
((donny.kwok@thomsonreuters.com))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.